摘要
目的:研究乳化异氟醚(EI)预处理对大鼠肺缺血再灌注肺损伤的保护机制。方法:雄性Wistar大鼠随机分为对照组、模型组、脂肪乳组和EI组。除对照组外,其余3组均参照改良的Eppinger方法建立大鼠肺缺血再灌注损伤模型,脂肪乳组和EI组在建模前分别作脂肪乳和EI预处理。评价各组大鼠肺组织病理形态变化;测定肺组织髓过氧化物酸(MPO)、肿瘤坏死因子-α(TNF-α)水平;免疫组织化学和免疫印迹检测各组大鼠肺组织中核转录因子κB(NF-κB)的表达。结果:肺缺血再灌注2h后,模型组肺组织MPO、TNF-α含量升高,高于对照组及乳化异氟醚组,有统计学意义;模型组NF-κB表达量较高,与脂肪乳组无差异,但与其余2组差异均具有统计学意义;EI组与对照组比较,差异无统计学意义。结论:乳化异氟醚预处理可减轻肺缺血再灌注损伤,其机制可能是通过抑制NF-κB信号通路发挥作用。
Objective: To investigate the protective mechanism of emulsified isoflurane pretreatment on the lung ischemia/ reperfusion injury in rats. Methods: Male Wistar rats were randomly divided into control group, model group, lipid emulsion group(LE group) and emulsified isoflurane group(El group). Except for the control group, the remaining 3 groups were established by the modified Eppinger method; LE group and EI group were pretreated with lipid emulsion and emulsified isoflurane before modeling. Lung tissues were restored to analyze the pathological changes; The level of lung tissue myeloperoxidase(MPO) and TNF-α were determined; The expression of NF-κB in the lung tissues was tested by immunohistochemical staining and Western blotting. Results: Two hours after reperfusion, the MPO and TNF-α levels of model group were significantly higher than the control group and EI group. There was significantly higher expression of NF- κB in the model group than the other 3 groups, but no significant difference was found between the model group and the LE group. There was no significant difference in the NF-κB expression level between the control group and the EI group. Conclusion: The emulsified isoflurane pretreatment can protect the lung against ischemia/reperfusion injury by inhibiting the activation of NF-κB signal pathway.
作者
霍东升
孙建芳
赵志英
贾建新
Huo Dongsheng Sun Jianfang Zhao Zhiying Jia Jianxin(Departmentof HumanAnatomy FirstAffiliated Hospital, BaotouMedical College, Baotou 014040, China)
出处
《解剖学杂志》
CAS
CSCD
北大核心
2016年第5期553-556,共4页
Chinese Journal of Anatomy
基金
包头市医药卫生基金(Wsjj2015019)
关键词
缺血再灌注损伤
乳化异氟醚
预处理
核转录因子ΚB
大鼠
ischemia/reperfusion injury
emulsified isoflurane
pretreatment
nuclear factor kappa B
rat